Rheumatoid arthritis oral abstractsO01. Efficacy and Safety of Baricitinib Versus Placebo and Adalimumab in Patients with Moderately to Severely Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Summary Results from the 52-Week Phase 3 RA-Beam Study

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2017-04, Vol.56 (suppl_2), p.ii26-ii29
Main Authors: Taylor, Peter C., Krogulec, Marek, Dudek, Anna, Dudler, Jean, Drescher, Edit, Cseuz, Regina, Kausiene, Rasa, Andersone, Daina, Unikiene, Dalia, Burson, Juan Sanchez, Alonso, Ricardo Blanco, Dvořák, Zdeněk, Ghizdavescu, Andrei, Irto, Ildiko, Larsson, Esbjörn, Bello, Natalia, Barry, Jane, Durand, Frederick, Holzkämper, Thorsten, Otawa, Susan, de Bono, Stephanie, Keystone, Edward C., Rubbert-Roth, Andrea, Combe, Bernard, De La Torre, Inmaculada
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/kex061